France· FR:61084408
BROMAZEPAM ARROW 1,5 mg, comprimé
A bromazepam product containing bromazépam, registered in France by ARROW GENERIQUES, on the national reimbursement list. The same ATC class is registered in 13 of our 19 countries.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
Where it is registered
Bromazepam is registered in 13 of 19 countries.
Countries holding a registration under ATC N05BA08 (bromazepam), each read from that country’s own register.
- This record: France, from Base de données publique des médicaments — BDPM (France)
- 6 of them publish a price we can compare per daily dose
Bromazepam · ATC N05BA08
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Franceprice
- Germany
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
Price per daily dose
What a daily dose of bromazepam costs, country by country.
Normalised to the WHO defined daily dose (10 mg), the median price runs from $0.11 in France to $1.17 in Switzerland — a ×11 gap.
- France: $0.11 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
Bromazepam · price per daily dose (10 mg)
USD · FX 28 Sept 2026
- CH Switzerland$1.17
- FR France$0.11
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- BROMAZÉPAM
- Manufacturer
- ARROW GENERIQUES
- Country
- France (FR)
- ATC code
- N05BA08
- ATC class
- Bromazepam
- Defined daily dose
- 10 mg, O
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cip133400927713972plaquette(s) thermoformée(s) PVC-Aluminium de 120 comprimé(s)EUR 1.84
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
49 interactions on record for bromazepam.
Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Bromazepam · interactions on record
49 records
49 more interactions with mechanism and management, from a commercially licensed source.
Sign in to checkSame medicine, other countries
Bromazepam in 10 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaBROMAZEPAM MEDREGMEDREG s.r.o., Praha
- SwitzerlandLexotanil 1,5, TablettenCheplapharm Schweiz GmbH
- IrelandLexotan 1.5mg TabletsCHEPLAPHARM Arzneimittel GmbH
- PolandBromoxOrion Corporation
- BelgiumBromatop 12 mgApotex
- GermanyBromazanilHexal Ag
- CanadaAPO-BROMAZEPAMAPOTEX INC
- NetherlandsBromazepam Sandoz 3, tabletten 3 mgSandoz B.V.
Authorised across Europe · EMA
The same active substance is authorised in 23 EEA countries. Names it is sold under:
- Austria · Bromazepam G.L., Bromazepam Genericon
- Belgium · Bromazepam Eg, Bromazepam Sandoz
- Bulgaria · Брелакс, Лексотан
- Cyprus · Akamon, Amant
- Czechia · Becalen, Bromazepam Medreg
- Germany · Bromazanil, Bromazep Ct Abz-Pharma
- Denmark · Lexotan
- Estonia · Bromazepam Lannacher
- Spain · Bromazepam Kern Pharma, Bromazepam Normon
- Greece · Lexotanil, Notorium
- Croatia · Bromazepam Inn-Farm, Lexaurin
- Ireland · Lexotan
- Italy · Bromazepam Abc, Bromazepam Accord
- Lithuania · Bromazepam Lannacher, Lexotanil
- Luxembourg · Bromazepam Eg, Lexotan
- Latvia · Bromazepam Lannacher, Lexotanil
- Malta · Akamon, Lexilium
- Netherlands · Bromazepam Sandoz
- Poland · Bromox, Lexotan
- Portugal · Bromalex, Bromazepam Pharmakern
- Romania · Bromazepam Arena, Bromazepam Lph Labormed
- Slovenia · Bromazepam Inn-Farm, Lexaurin
- Slovakia · Bromazepam Medochemie, Bromazepam Medreg
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c43c5525-dc81-499b-8b8a-b844c728c317 GET /v1/drugs/c43c5525-dc81-499b-8b8a-b844c728c317?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "61084408",
"date_amm": "2014-02-06",
"type_amm": "Procédure nationale",
"numero_ue": null,
"substance": "BROMAZÉPAM",
"atc_source": "fr_atc_restore_2026-09-06",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "comprimé",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about bromazepam.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.